NCT02418312View on ClinicalTrials.gov

Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer

NACompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Peptic Ulcer
Interventions
DRUG

histamine-2 receptor antagonist

famotidine 40 mg qd plus thienopyridine

DRUG

Placebo

placebo plus thienopyridine

Trial Locations (1)

813

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Veterans General Hospital.

OTHER

NCT02418312 - Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer | Biotech Hunter | Biotech Hunter